Norges Bank Ptc Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $372,819 - $605,812
15,100 New
15,100 $461,000
Q4 2023

Feb 09, 2024
BUY
$18.07 - $29.37 $9.87 Million - $16 Million
546,375 New
546,375 $15.1 Million
Q3 2023

Nov 13, 2024
BUY
$22.41 - $41.99 $12 Million - $22.4 Million
533,875 New
533,875 $12 Million
Q3 2023

Nov 13, 2023
SELL
$22.41 - $41.99 $15.5 Million - $29.1 Million
-692,074 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$40.4 - $59.1 $20.8 Million - $30.4 Million
514,975 Added 3410.43%
530,075 $21.6 Million
Q2 2023

Aug 14, 2023
SELL
$40.4 - $59.1 $27.5 Million - $40.2 Million
-680,928 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$38.16 - $48.86 $21.8 Million - $27.9 Million
570,451 New
570,451 $27.6 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $21.6 Million - $35.3 Million
644,157 New
644,157 $24.6 Million
Q3 2022

Nov 13, 2023
BUY
$41.85 - $53.85 $29 Million - $37.3 Million
692,074 New
692,074 $34.7 Million
Q2 2022

Aug 14, 2023
BUY
$25.6 - $45.23 $17.4 Million - $30.8 Million
680,928 New
680,928 $27.3 Million
Q1 2022

May 12, 2023
SELL
$33.33 - $44.6 $2.71 Million - $3.63 Million
-81,341 Reduced 12.63%
562,816 $21 Million
Q1 2022

May 09, 2022
SELL
$33.33 - $44.6 $13.8 Million - $18.5 Million
-414,626 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$35.36 - $41.86 $14.7 Million - $17.4 Million
414,626 New
414,626 $16.5 Million
Q3 2021

Nov 14, 2022
BUY
$37.01 - $44.74 $20.3 Million - $24.6 Million
549,140 New
549,140 $20.4 Million
Q3 2021

Nov 05, 2021
SELL
$37.01 - $44.74 $19.2 Million - $23.2 Million
-519,412 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$37.95 - $49.37 $19.7 Million - $25.6 Million
519,412 New
519,412 $22 Million
Q2 2021

Aug 10, 2021
SELL
$37.95 - $49.37 $16.9 Million - $22 Million
-445,746 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$46.8 - $68.92 $20.9 Million - $30.7 Million
445,746 New
445,746 $21.1 Million
Q1 2021

May 07, 2021
SELL
$46.8 - $68.92 $25.9 Million - $38.2 Million
-554,290 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$47.96 - $67.64 $26.6 Million - $37.5 Million
554,290 New
554,290 $33.8 Million
Q4 2020

Feb 10, 2021
SELL
$47.96 - $67.64 $24.3 Million - $34.3 Million
-507,129 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$45.41 - $57.07 $23 Million - $28.9 Million
507,129 New
507,129 $23.7 Million
Q3 2020

Nov 10, 2020
SELL
$45.41 - $57.07 $26.1 Million - $32.8 Million
-573,883 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$42.56 - $54.98 $24.4 Million - $31.6 Million
573,883 New
573,883 $29.1 Million
Q2 2020

Aug 07, 2020
SELL
$42.56 - $54.98 $28.6 Million - $37 Million
-672,512 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$32.37 - $59.36 $21.8 Million - $39.9 Million
672,512 New
672,512 $30 Million
Q1 2020

May 08, 2020
SELL
$32.37 - $59.36 $21.3 Million - $39.1 Million
-659,192 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$32.22 - $50.07 $21.2 Million - $33 Million
659,192 New
659,192 $31.7 Million
Q4 2019

Feb 12, 2020
SELL
$32.22 - $50.07 $20.4 Million - $31.8 Million
-634,317 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$33.82 - $48.17 $21.5 Million - $30.6 Million
634,317 New
634,317 $21.5 Million
Q3 2019

Nov 08, 2019
SELL
$33.82 - $48.17 $20.8 Million - $29.6 Million
-614,493 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$35.42 - $45.0 $21.8 Million - $27.7 Million
614,493 New
614,493 $27.7 Million
Q2 2019

Aug 09, 2019
SELL
$35.42 - $45.0 $3.84 Million - $4.88 Million
-108,370 Closed
0 $0
Q1 2019

May 11, 2020
SELL
$28.09 - $39.49 $480,001 - $674,805
-17,088 Reduced 13.62%
108,370 $4.08 Million
Q3 2016

Nov 13, 2017
BUY
N/A
125,458
125,458 $0

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email